Desperate patients and helpless medical staff at Jamshetji Jeejeebhoy (JJ) hospital are grappling with the shortage of medicines, most of which have been listed as out of stock.
Not much Covaxin supply seen from PSUs till early next year - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
Phase-3 Trials Show Covaxin 93 4 Per Cent Effective Against Severe COVID-19 But Supply Marred By Delay In Manufacturing swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
Haffkine Biopharma to produce 22.8 cr doses of Covaxin per annum
With the aim of vaccinating the entire eligible population at the earliest, domestic vaccine production is being steadily ramped up in the country with the help from the Centre
Photo Courtesy: IANS
Engagement: 0
The Centre on Wednesday took steps to accelerate domestic vaccine production. Mumbai-based Haffkine Biopharma will produce 22.8 crore doses per annum of Covaxin under technology transfer arrangement with Bharat Biotech.
With the aim of vaccinating the entire eligible population at the earliest, domestic vaccine production is being steadily ramped up in the country with the help from the Centre.